The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
- PMID: 36989901
- DOI: 10.1016/j.intimp.2023.110081
The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
Erratum in
-
Corrigendum to "The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics" [Int. Immunopharmacol. 118 (2023) 110081].Int Immunopharmacol. 2023 Dec;125(Pt A):111089. doi: 10.1016/j.intimp.2023.111089. Epub 2023 Oct 21. Int Immunopharmacol. 2023. PMID: 37872057 No abstract available.
Abstract
The complement system is one of the oldest known tightly regulated host defense systems evolved for efficiently functioning cell-based immune systems and antibodies. Essentially, the complement system acts as a pivot between the innate and adaptive arms of the immune system. The complement system collectively represents a cocktail of ∼50 cell-bound/soluble glycoproteins directly involved in controlling infection and inflammation. Activation of the complement cascade generates complement fragments like C3a, C4a, and C5a as anaphylatoxins. C5a is the most potent proinflammatory anaphylatoxin, which is involved in inflammatory signaling in a myriad of tissues. This review provides a comprehensive overview of human C5a in the context of its structure and signaling under several pathophysiological conditions, including the current and future therapeutic applications targeting C5a.
Keywords: C5a; C5aR1, C5aR2; Disease; Therapeutics.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
